Case Study: Genesis Therapeutics achieves faster AI drug discovery with Lambda

How Genesis Therapeutics Scaled AI-Driven Drug Discovery with Lambda

Genesis Therapeutics, an AI-driven drug discovery company, faced significant computational bottlenecks as it scaled its research. Their AI models for analyzing protein interactions required immense processing power, leading to training times that stretched to months and hindering their ability to iterate quickly. To overcome these scalability and networking issues, they partnered with vendor Lambda.

By leveraging Lambda's high-performance NVIDIA H100 GPU clusters with NVIDIA Quantum-2 InfiniBand networking, Genesis Therapeutics accelerated its research. The solution, implemented via Lambda's 1-Click Clusters, reduced model training times by 3x, from months down to a week. This allowed Genesis to process larger datasets, improve model accuracy, and focus on its core mission of targeting previously undruggable proteins, all while Lambda managed the complex infrastructure.

Genesis Therapeutics

Wojtek Swiderski

Director of Software Engineering